These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 116292)

  • 21. Pharmacokinetic implications of different oil vehicles used in depot neuroleptic treatment.
    Knudsen P; Hansen LB; Larsen NE
    Acta Psychiatr Scand Suppl; 1985; 322():7-10. PubMed ID: 3865501
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fluctuation of serum zuclopenthixol concentrations in patients treated with zuclopenthixol decanoate in viscoleo.
    Poulsen JH; Olesen OV; Larsen NE
    Ther Drug Monit; 1994 Apr; 16(2):155-9. PubMed ID: 8009563
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma flupentixol concentrations and clinical response in acute schizophrenia.
    Balant-Gorgia AE; Eisele R; Aeschlimann JM; Balant LP; Garrone G
    Ther Drug Monit; 1985; 7(4):411-4. PubMed ID: 4082241
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Flupentixol and flupentixol decanoate, with special reference to their antipsychotic effect.
    Gottfries CG
    Acta Psychiatr Belg; 1974 Sep; 74(5):507-16. PubMed ID: 4620362
    [No Abstract]   [Full Text] [Related]  

  • 25. Serum concentration of depot neuroleptics in tardive dyskinesia.
    Fairbairn AF; Rowell FJ; Hui SM; Hassanyeh F; Robinson AJ; Eccleston D
    Br J Psychiatry; 1983 Jun; 142():579-83. PubMed ID: 6882980
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stereoselective disposition of flupentixol: influence on steady-state plasma concentrations in schizophrenic patients.
    Balant-Gorgia AE; Balant LP; Gex-Fabry M; Genet C
    Eur J Drug Metab Pharmacokinet; 1987; 12(2):123-8. PubMed ID: 3691577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High dose flupenthixol decanoate in chronic schizophrenia.
    McCreadie RG; Flanagan WL; McKnight J; Jorgensen A
    Br J Psychiatry; 1979 Aug; 135():175-9. PubMed ID: 387151
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Studies on the long acting neuroleptic agent flupenthixol decanoate--a review (author's transl)].
    Sieberns S
    Pharmakopsychiatr Neuropsychopharmakol; 1978 Jul; 11(4):186-98. PubMed ID: 674354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of a 50% reduction of cis(z)-flupenthixol decanoate in chronic schizophrenic patients maintained on a high dose regime.
    Cookson IB
    Int Clin Psychopharmacol; 1987 Apr; 2(2):141-9. PubMed ID: 3298419
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Depot flupenthixol decanoate for schizophrenia or other similar psychotic disorders.
    Quraishi S; David A
    Cochrane Database Syst Rev; 2000; (2):CD001470. PubMed ID: 10796442
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clopenthixol and flupenthixol depot preparations in outpatient schizophrenics. I. A one year double-blind study of clopenthixol decanoate and flupenthixol palmitate.
    Dencker SJ; Lepp M; Malm U
    Acta Psychiatr Scand Suppl; 1980; 279():10-28. PubMed ID: 6931470
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A new injectable delayed-action neuroleptic with sedative and antipsychotic action: cis-(Z)-clopenthixol decanoate. Clinical trials].
    Lambert PA; Chabannes JP
    Encephale; 1984; 10(2):83-91. PubMed ID: 6381033
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Dose and serum drug level and its clinical effects during the long-term treatment of chronic schizophrenia with flupenthixol depot].
    Lipska B; Szukalski B; Nurowska K; Welbel L
    Psychiatr Pol; 1986; 20(1):1-7. PubMed ID: 3725983
    [No Abstract]   [Full Text] [Related]  

  • 34. Radioimmunoassay for flupenthixol in plasma.
    Robinson JD; Risby D
    Clin Chem; 1977 Nov; 23(11):2085-8. PubMed ID: 912874
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Depot neuroleptic medication and serum levels by radioreceptor assay: prolactin concentration, electrocardiogram abnormalities and six-month outcome.
    Turbott J; Villiger J; Hunter L
    Aust N Z J Psychiatry; 1987 Sep; 21(3):327-38. PubMed ID: 3435373
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [cis(Z)-Clopenthixol decanoate--a new depot neuroleptic].
    Sieberns S; Spechtmeyer H
    Int Pharmacopsychiatry; 1982; 17(3):170-84. PubMed ID: 7141812
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetic studies on flupenthixol decanoate, a depot neuroleptic of the thioxanthene group.
    Jørgensen A
    Drug Metab Rev; 1978; 8(2):235-49. PubMed ID: 720214
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparative study of the pharmacokinetics of zuclopenthixol decanoate and fluphenazine decanoate.
    Viala A; Ba B; Durand A; Gouezo F; Hou N; Jørgensen A
    Psychopharmacology (Berl); 1988; 94(3):293-7. PubMed ID: 2895936
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Action of flupentixol decanoate in chronic psychoses of the schizophrenic type].
    Evrard E; Heusghem C; Molders V; Plomteux G; Lebas A
    Acta Psychiatr Belg; 1972 Sep; 72(5):573-94. PubMed ID: 4669430
    [No Abstract]   [Full Text] [Related]  

  • 40. The long-term treatment of periodical and cyclic depressions with flupenthixol decanoate.
    Kielholz P; Terzani S; Pöldinger W
    Int Pharmacopsychiatry; 1979; 14(6):305-9. PubMed ID: 548504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.